The finding that the XIAP overexpression is associated with a favorable outcome is contradictory to findings from us and others in different tumor entities, such as esophageal cancer (Schiffmann et al. 2019) and melanoma (Daoud et al. 2022). This evidence concerns the gene XIAP and neoplasm.